1. Home
  2. PAHC vs PGEN Comparison

PAHC vs PGEN Comparison

Compare PAHC & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

N/A

Current Price

$48.49

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$3.52

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAHC
PGEN
Founded
1946
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
PAHC
PGEN
Price
$48.49
$3.52
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
$34.33
$7.67
AVG Volume (30 Days)
232.7K
4.7M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
1.00%
N/A
EPS Growth
1883.33
N/A
EPS
1.32
N/A
Revenue
$833,350,000.00
$230,981,000.00
Revenue This Year
$17.03
$342.78
Revenue Next Year
$3.82
$478.46
P/E Ratio
$36.22
N/A
Revenue Growth
4.12
N/A
52 Week Low
$16.16
$1.11
52 Week High
$56.30
$5.47

Technical Indicators

Market Signals
Indicator
PAHC
PGEN
Relative Strength Index (RSI) 47.64 38.32
Support Level $37.09 $3.49
Resistance Level $56.14 $5.10
Average True Range (ATR) 2.27 0.29
MACD -0.94 -0.09
Stochastic Oscillator 26.88 14.68

Price Performance

Historical Comparison
PAHC
PGEN

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: